نتائج البحث

Hematologic Neoplasms Associated with Down Syndrome: Cellular and Molecular Heterogeneity of the Diseases.

• Authors : Peroni E; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, 35128 Padova, Italy.; Gottardi M

Subjects: Down Syndrome*/Down Syndrome*/Down Syndrome*/complications ; Down Syndrome*/Down Syndrome*/Down Syndrome*/genetics ; Down Syndrome*/Down Syndrome*/Down Syndrome*/pathology

• Source: International journal of molecular sciences [Int J Mol Sci] 2023 Oct 18; Vol. 24 (20). Date of Electronic Publication: 2023 Oct 18.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

Recent advances in the roles of exosomal microRNAs (exomiRs) in hematologic neoplasms: pathogenesis, diagnosis, and treatment.

• Authors : Jahromi FNA; Department of Hematology, School of Paramedical, Shiraz University of Medical Sciences, Shiraz, Iran.; Dowran R

Subjects: MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics ; Neoplasms*/Neoplasms*/Neoplasms*/genetics ; Exosomes*/Exosomes*/Exosomes*/metabolism

• Source: Cell communication and signaling : CCS [Cell Commun Signal] 2023 May 01; Vol. 21 (1), pp. 88. Date of Electronic Publication: 2023 May 01.Publisher: BioMed Central Country of Publication: England NLM ID: 101170464 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-811X

تفاصيل العنوان

EBF1, PAX5, and MYC: regulation on B cell development and association with hematologic neoplasms

• Authors : Li Li; Daiquan Zhang; Xinmei Cao

Subjects: EBF1; PAX5; MYC

• Source: Frontiers in Immunology, Vol 15 (2024)

تفاصيل العنوان

Participation and Influencing Factors in the Decision-Making of Life-Sustaining Treatment: A Focus on Deceased Patients with Hematologic Neoplasms.

• Authors : Jae Eun Jang¹; Jeong Moon Ryu¹; Min Hee Heo¹

• Source: Journal of Hospice & Palliative Care. Jun2023, Vol. 26 Issue 2, p69-79. 11p.

تفاصيل العنوان

Recent advances in the roles of exosomal microRNAs (exomiRs) in hematologic neoplasms: pathogenesis, diagnosis, and treatment

• Authors : Faride Nam Avar Jahromi; Razieh Dowran; Reza Jafari

Subjects: Biomarker; Drug delivery; Hematologic neoplasms

• Source: Cell Communication and Signaling, Vol 21, Iss 1, Pp 1-11 (2023)

تفاصيل العنوان

Cytokine-induced killer cells: new insights for therapy of hematologic malignancies.

• Authors : Ghanbari Sevari F; Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.; Mehdizadeh A

Subjects: Cytokine-Induced Killer Cells*/Cytokine-Induced Killer Cells*/Cytokine-Induced Killer Cells*/immunology ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/therapy ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/immunology

• Source: Stem cell research & therapy [Stem Cell Res Ther] 2024 Aug 13; Vol. 15 (1), pp. 254. Date of Electronic Publication: 2024 Aug 13.Publisher: BioMed Central Country of Publication: England NLM ID: 101527581 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-6512

تفاصيل العنوان

Multi-omics analysis identifies repurposing bortezomib in the treatment of kidney-, nervous system-, and hematological cancers.

• Authors : Larsson P; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. .; Sahlgrenska Center for Cancer Research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. .

Subjects: Bortezomib*/Bortezomib*/Bortezomib*/pharmacology ; Bortezomib*/Bortezomib*/Bortezomib*/therapeutic use ; Drug Repositioning*/Drug Repositioning*/Drug Repositioning*/methods

• Source: Scientific reports [Sci Rep] 2024 Aug 10; Vol. 14 (1), pp. 18576. Date of Electronic Publication: 2024 Aug 10.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Novel natural killer cell-based therapies for hematologic and solid malignancies: latest updates from ASCO 2024.

• Authors : Gong X; Department of Clinical Laboratory, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310000, P.R. China.; Zhang L

Subjects: Killer Cells, Natural*/Killer Cells, Natural*/Killer Cells, Natural*/immunology ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/therapy ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/immunology

• Source: Journal of hematology & oncology [J Hematol Oncol] 2024 Jul 29; Vol. 17 (1), pp. 57. Date of Electronic Publication: 2024 Jul 29.Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722

تفاصيل العنوان

Impact of multidrug resistance on outcomes in hematologic cancer patients with bacterial bloodstream infections.

• Authors : Park KH; Department of Infectious Diseases, Kyung Hee University College of Medicine, Seoul, Republic of Korea.; Jung YJ

Subjects: Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/complications ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/microbiology ; Drug Resistance, Multiple, Bacterial*

• Source: Scientific reports [Sci Rep] 2024 Jul 07; Vol. 14 (1), pp. 15622. Date of Electronic Publication: 2024 Jul 07.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Leukemic Stem Cells and Hematological Malignancies.

• Authors : Choi HS; Department of Convergence Medicine, School of Medicine, Pusan National University, Yangsan 50612, Republic of Korea.; Kim BS

Subjects: Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/genetics ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/pathology ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/metabolism

• Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jun 17; Vol. 25 (12). Date of Electronic Publication: 2024 Jun 17.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان